Yuancheng gold(SH:600766)2024-05-31 11:52Financial Performance - The company's operating revenue for Q3 2023 was CNY 32,064,166.98, a decrease of 14.94% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was a loss of CNY 2,837,710.65, representing a decline of 1598.10% year-over-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of CNY 2,660,319.73, down 1504.45% from the previous year[5]. - The basic earnings per share for Q3 2023 was -0.013, a decrease of 1400.00% year-over-year[6]. - The weighted average return on net assets was -4.77%, a decrease of 5.09 percentage points compared to the previous year[6]. - The net loss for Q3 2023 was -2,022,376.56 RMB, compared to -868,967.67 RMB in Q3 2022, indicating a significant increase in losses[20]. - Operating profit for Q3 2023 was -470,305.13 RMB, an improvement from -1,333,807.42 RMB in the same period last year[20]. - The net loss for the first three quarters of 2023 was CNY 4,353,953.78, compared to a net loss of CNY 2,884,926.87 in the same period of 2022[30]. Cash Flow and Liquidity - The cash flow from operating activities for the year-to-date was CNY 14,656,082.82, an increase of 145.63% compared to the same period last year[6]. - Cash flow from operating activities for the first nine months of 2023 was 33,984,125.73 RMB, a recovery from -62,093,506.79 RMB in the previous year[24]. - The company reported a significant increase in cash received from operating activities, totaling 423,015,442.63 RMB in Q3 2023, compared to 399,359,831.02 RMB in Q3 2022[24]. - Total cash and cash equivalents at the end of Q3 2023 amounted to 41,352,434.35 RMB, up from 578,620.68 RMB at the end of Q3 2022[25]. - Cash and cash equivalents as of September 30, 2023, amounted to RMB 145,352,434.35, down from RMB 297,741,218.56 at the end of 2022, reflecting a decrease of approximately 51.2%[14]. Assets and Liabilities - The total assets at the end of Q3 2023 were CNY 309,661,168.10, a decrease of 31.10% compared to the end of the previous year[6]. - The company's total assets as of September 30, 2023, were RMB 309,661,168.10, down from RMB 449,454,338.98 at the end of 2022, indicating a decrease of approximately 30.9%[17]. - Total liabilities amounted to CNY 183,793,669.76, up from CNY 99,333,390.16, reflecting a rise of approximately 84.9%[28]. - Total current liabilities decreased to RMB 240,579,624.42 from RMB 392,339,853.87, a decline of about 38.7%[16]. - The company's total non-current assets decreased slightly to CNY 124,697,002.35 from CNY 128,090,157.39[28]. Equity and Investments - The equity attributable to shareholders at the end of Q3 2023 was CNY 63,776,958.01, an increase of 11.66% compared to the end of the previous year[6]. - The company's total equity increased to RMB 69,081,543.68 from RMB 57,114,485.11, reflecting an increase of about 21%[17]. - The total equity increased to CNY 55,766,501.74 from CNY 51,680,383.50, showing an increase of about 7.5%[28]. - The capital reserve increased to RMB 245,577,360.03 from RMB 237,087,924.90, showing a growth of approximately 3.3%[17]. - The company received 5,500,000.00 RMB from investment in Q3 2023, while total cash inflow from financing activities was 15,500,000.00 RMB[25]. Operating Costs and Revenue Growth - The company reported a significant increase in operating costs, with a year-to-date increase of 157.09% attributed to higher sales costs[10]. - Total operating revenue for the first three quarters of 2023 reached RMB 110,263,510.84, a significant increase from RMB 43,930,020.60 in the same period of 2022, representing a growth of approximately 151.1%[19]. - Total operating costs for the first three quarters of 2023 were RMB 110,849,673.25, compared to RMB 45,134,081.84 in 2022, indicating an increase of about 145.5%[19]. - Operating revenue for the first three quarters of 2023 reached CNY 43,431,225.25, a significant increase from CNY 357,129.54 in the same period of 2022[29]. Research and Development - The company has not disclosed any new product developments or market expansion strategies in the current report[10]. - Research and development expenses were not explicitly detailed but are part of the overall management expenses of CNY 1,449,899.99, which decreased from CNY 1,513,219.34[30].